Bombay HC Conducts Emergency Hearing from CJ’s Residence as Court Staff Deployed for Elections || Madras HC: Preventive Detention Laws are Draconian, Cannot be Used to Curb Dissent or Settle Politics || HP HC: Mere Interest in a Project Cannot Justify Impleading a Non-Signatory in Arbitration || J&K&L HC: Women Accused in Non-Bailable Offences Form a Distinct Class Beyond Sec 437 CrPC Rigour || Bombay HC Restores IMAX’s Enforcement of Foreign Awards Against E-City, Applying Res Judicata || Supreme Court Upholds Cancellation of Bail For Man Accused of Assault Causing Miscarriage || J&K&L High Court Invalidates Residence-Based Reservation, Citing Violation of Article 16 || Kerala HC Denies Parole to Life Convict in TP Chandrasekharan Murder Case For Cousin's Funeral || High Court Grants Bail to J&K Bank Manager in Multi-Crore Loan Fraud Case, Emphasizing Bail As Rule || J&K HC: Civil Remedy Alone Cannot Be Used To Quash Criminal Proceedings in Enso Tower Case

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :